Covered recipient · General Payments record
NIXI CAT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,204.74
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.91 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $176.03 | 8 |
| Sumitomo Pharma America, Inc. | $96.33 | 4 |
| Novo Nordisk AS | $76.15 | 4 |
| Amgen Inc. | $31.68 | 2 |
| PFIZER INC. | $22.02 | 1 |
| DEXCOM, INC. | $21.79 | 1 |
| Biogen, Inc. | $20.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.69 | 1 |
| Acerta Pharma LLC | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.90 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428868 | CMS |
| ABBVIE INC. | $11.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428870 | CMS |
| ABBVIE INC. | $30.70 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428872 | CMS |
| ABBVIE INC. | $14.85 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428874 | CMS |
| ABBVIE INC. | $21.80 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428876 | CMS |
| ABBVIE INC. | $26.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428878 | CMS |
| ABBVIE INC. | $30.22 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428880 | CMS |
| ABBVIE INC. | $17.98 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428882 | CMS |
| Amgen Inc. | $15.23 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115485460 | CMS |
| Amgen Inc. | $16.45 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115485468 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.09 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104672703 | CMS |
| Biogen, Inc. | $20.13 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860410 | CMS |
| Dexcom, Inc. | $21.79 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153326087 | CMS |
| Novartis Pharmaceuticals Corporation | $15.69 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086773493 | CMS |
| Novo Nordisk Inc | $13.30 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096944228 | CMS |
| Novo Nordisk Inc | $16.69 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097245933 | CMS |
| Novo Nordisk Inc | $23.71 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096984037 | CMS |
| Novo Nordisk Inc | $22.45 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097116531 | CMS |
| PFIZER INC. | $22.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131894120 | CMS |
| Sumitomo Pharma America, Inc. | $28.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835895 | CMS |
| Sumitomo Pharma America, Inc. | $22.74 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835897 | CMS |
| Sumitomo Pharma America, Inc. | $21.79 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835899 | CMS |
| Sumitomo Pharma America, Inc. | $23.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835901 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.